Threshold levels of ABL tyrosine kinase inhibitors retained in chronic myeloid leukemia cells determine their commitment to apoptosis
Thomas O'Hare, Christopher A. Eide, Anupriya Agarwal, Lauren T. Adrian, Matthew S. Zabriskie, Ryan J. MacKenzie, Dorian H. La Tocha, Kara J. Johnson, Huihong You, Jenny Luo, Steven M. Riddle, Bryan D. Marks, Kurt W. Vogel, Dennis R. Koop, John Apgar, Jeffrey W. Tyner, Michael W. Deininger, Brian J. Druker
Dive into the research topics of 'Threshold levels of ABL tyrosine kinase inhibitors retained in chronic myeloid leukemia cells determine their commitment to apoptosis'. Together they form a unique fingerprint.